Farther Finance Advisors »

Cytomx Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 8.0k 3.19

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Microsoft Corp Stock (MSFT)
Dimensional International Value Etf Etf (DFIV)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Oreilly Automotive Stock (ORLY)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)

View all positions for Farther Finance Advisors

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Tang Capital Management
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Balyasny Asset Management
Baker Bros. Advisors
Point72 Asset Management
ADAR1 Capital Management
Kynam Capital Management
Rtw Investments
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics